ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.
Duchenne muscular dystrophy (DMD) is the most common inherited neuromuscular disease and is characterized by absence of the cytoskeletal protein dystrophin, muscle wasting, and fibrosis. We previously demonstrated that systemic infusion or oral administration of angiotensin-(1-7) (Ang-(1-7)), a pept...
Saved in:
| Main Authors: | Cecilia Riquelme, María José Acuña, Javiera Torrejón, Daniela Rebolledo, Daniel Cabrera, Robson A Santos, Enrique Brandan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0093449&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impaired adaptive response to mechanical overloading in dystrophic skeletal muscle.
by: Pierre Joanne, et al.
Published: (2012-01-01) -
Dysregulated ATX-LPA and YAP/TAZ signaling in dystrophic Sgcd −/− mice with early fibrosis and inflammation
by: Cristian Gutiérrez-Rojas, et al.
Published: (2025-03-01) -
Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice.
by: Jinhong Meng, et al.
Published: (2011-03-01) -
FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacy
by: Maxime Ferrand, et al.
Published: (2025-09-01) -
Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
by: Rafael Dias Mâncio, et al.
Published: (2017-01-01)